Conduit Pharmaceuticals partners with Charles River to evaluate AZD1656 for lupus, enhancing preclinical research and improving Phase II trial success. Conduit Pharmaceuticals has announced a ...
Charles River Laboratories International, Inc. (NYSE: CRL) has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today a collaboration with the FOXG1 Research Foundation (FRF) highlighting the patient ...
Charles River Laboratories International operates in the healthcare sector, providing regulated research services and ...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...
Charles River Development (CRD) has welcomed Vinayak Baht as senior vice president and head of Asia Pacific. In the role, he will be responsible for all business oversight within the region and ...
Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles River Investment Management ...
BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today that Operadora de Fondos Banorte, SA de CV, SOFI, Grupo Financiero Banorte ("BANORTE"), one of Mexico’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback